Hydrogen sulfide and epigenetics: Novel insights into the cardiovascular effects of this gasotransmitter

Epigenetics studies the heritable modifications of genome expression that do not affect the nucleotide sequence. Epigenetic modifications can be divided into: DNA methylation, histone modifications, and modulation of genome expression by non-coding RNAs. Alteration of these mechanisms can alter the phenotype, and can lead to disease onset. The endogenous gasotransmitter hydrogen sulfide (H2S) plays pleiotropic roles in many systems, including the cardiovascular (CV) system, and its mechanism of action mainly includes S-persulfidation of cysteine residues. Recent evidence suggests that many H2S-mediated biological activities are based on the epigenetic regulation of cellular function, with effects ranging from DNA methylation to modification of histones and regulation of non-coding RNAs. This review describes the role of H2S-regulating epigenetic mechanisms, providing a panorama of the current literature, and offers a novel scenario for the development of H2S-releasing 'epidrugs' with a potential clinical use in the prevention and treatment of many CV and non-CV disorders.

Automated summary

Epigenetics studies heritable modifications of genome expression, which do not affect the DNA sequence. Alterations in epigenetic mechanisms can impact phenotype and contribute to disease. Recent evidence suggests that hydrogen sulfide (H2S) plays a role in epigenetic regulation, from DNA methylation to histone modifications and non-coding RNA regulation. This review explores the potential for developing H2S-releasing "epidrugs" for the prevention and treatment of cardiovascular and non-cardiovascular disorders based on its regulatory role in epigenetics.